All
Assay reassures 'not all allergens created equal'
June 1st 2002New Orleans - Studies have shown that the local lymph node assay(LLNA) in mice can be used to provide quantitative estimates of the relativeskin sensitizing potency of various product ingredients, and these valuescorrelate closely with what is known of the ability of chemicals to causeskin sensitization in humans, G. Frank Gerberick, Ph.D., said at the annualAmerican Academy of Dermatology meeting.
Corticosteroid foams benefit acne keloidalis nuchae
June 1st 2002New Orleans - Clobetasol propionate and betamethasone valerate in a foam vehicle are effective for the treatment of acne keloidalis nuchae and have the advantage of better cosmetic acceptability compared with other formulations of topical steroids, Valerie D. Callender, M.D., said at the annual meeting of the American Academy of Dermatology.
Terbinafine shows dose-dependency in tinea capitis
June 1st 2002New Orleans - Dose rather than duration of therapy appears to be the important factor for achieving favorable cure rates using oral terbinafine (Lamisil) for the treatment of tinea capitis, Sheila Fallon Friedlander, M.D., said at the annual meeting of the American Academy of Dermatology.
EMLA, ELA-MAX, topicaine remain anesthetic standards
May 1st 2002New Orleans - Selecting an appropriate topical anesthetic agent requires a knowledge of the biochemistry and mechanisms of action of these agents to ensure efficacy and a quick onset of action, Christopher J. Arpey, M.D., said at the annual meeting of the American Academy of Dermatology.
Helpful hints for hard-to-heal wounds
May 1st 2002New Orleans - Chronic wound healing can be enhanced through a variety of products that encompass systemic agents such as pentoxifylline and aspirin to tissue-engineered skin and growth factors that stimulate healing, according to Robert S. Kirsner, MD.
Skin cancer Tx poses challenges to transplant patients
May 1st 2002New Orleans - Management of skin cancer in organ transplant recipientspresents numerous challenges, but there are also many opportunities fornew approaches that will improve the care of these patients, Clark C. Otley,M.D., said at the annual meeting of the American Academy of Dermatology.
Sorting through immunomodulatory psoriasis agents
May 1st 2002Norman Levine, M.D., professor and chief of dermatology, University of Arizona, and Gerald G. Krueger, M.D., professor of dermatology, Cumming Presidential Endowed Chair, University of Utah, discuss immunomodulatory agents in the treatment of psoriasis.